UroGen Pharma Ltd. Made Headway

Thu, Jun 13, 2024 at 07:18 PM

UroGen Pharma Ltd. (URGN:NASDAQ) rocketted at $17.5, a gain of 37.6%. On Thu, Jun 13, 2024, URGN:NASDAQ touched a New 2-Week High of $17.5. The stock got featured on our News Catalysts scanner on Thu, Jun 13, 2024 at 01:45 PM in the 'BIOTECH' category. From Thu, May 30, 2024, the stock recorded 40.00% Up Days and 45.45% Green Days

About UroGen Pharma Ltd. (URGN:NASDAQ)

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.

Top 10 Gainers:

Zapp Electric Vehicles Group Limited (ZAPP:NASDAQ), 239.86%
Nexalin Technology Inc. (NXL:NASDAQ), 120.99%
Histogen Inc. (HSTO:NASDAQ), 62.16%
Unico American Corporation (UNAM:NASDAQ), 50%
Longeveron Inc. (LGVN:NASDAQ), 48.62%
YY Group Holding Limited (YYGH:NASDAQ), 37.77%
UroGen Pharma Ltd. (URGN:NASDAQ), 37.58%
Neo-Concept International Group Holdings Limited (NCI:NASDAQ), 35.61%
Barnes & Noble Education, Inc. (BNED:NYSE), 33.33%
Aethlon Medical, Inc. (AEMD:NASDAQ), 31.46%